Standard Biotools (LAB) EBITDA Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 244.00 |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | -6,321.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,321.00 |
| Mar 31, 2026 | 696.00 |
| Dec 31, 2025 | -2,544.00 |
| Sep 30, 2025 | -5,528.00 |
| Jun 30, 2025 | 8,729.00 |
| Mar 31, 2025 | -2,960.00 |
| Sep 30, 2024 | -6,001.00 |
| Jun 30, 2024 | -7,720.00 |
| Mar 31, 2024 | -7,324.00 |
| Dec 31, 2023 | -3,797.00 |
| Sep 30, 2023 | -6,976.00 |
| Jun 30, 2023 | -1,040.00 |
| Mar 31, 2023 | -1,195.00 |
| Dec 31, 2022 | -4,983.00 |
| Sep 30, 2022 | -6,104.00 |
| Jun 30, 2022 | -15,347.00 |
| Mar 31, 2022 | -5,659.00 |
| Sep 30, 2021 | -2,073.00 |
| Jun 30, 2021 | -896.00 |
| Mar 31, 2021 | -888.00 |